Education: Master of Science in Engineering Physics from the Royal Institute of Technology, 1999.
Experience: Johan Liwing (born 1974) has more than 20 years’ experience in senior roles within the life sciences sector, having previously served as CEO of Lipigon Pharmaceuticals and XNK Therapeutics, as well as a long-standing career at Johnson & Johnson Innovative Medicine, where he held global commercial and senior leadership roles. He has a solid background in corporate leadership within the pharmaceutical and biotechnology sectors and brings with him experience of leading clinical-stage companies through critical development phases, partnership discussions and fundraising.
Warrants: 355,000
